Effects of an Out-of-Pocket Maximum in Medicare Part D
This study compares the impact of the 3 different out-of-pocket maximums proposed in Congress and by the Medicare Payment Advisory Commission.
Comparing Patient OOP Spending for Specialty Drugs in Medicare Part D and Employer-Sponsored Insurance
Out-of-pocket (OOP) spending for specialty drugs is substantially higher in Medicare Part D compared with employer-sponsored insurance because of the Part D benefit design.
